TOPAZIUM Clinical trials allows physicians to simultaneously map genetic, chemical, biochemistry and clinical patient’s conditions to identify “super-responders” or “super-resistant” clusters in a clinical study.

TOPAZIUM Clinical trials allows physicians to simultaneously map genetic, chemical, biochemistry and clinical patient’s conditions to identify “super-responders” or “super-resistant” clusters in a clinical study.

  Study type Design &
Development
Training &
Testing
Availability Access
Cancer Phase III    

Need more information?

CONTACT US